Avalos BR - Search Results

1

High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation.

Blum W, Bolwell BJ, Phillips G, Farag SS, Lin TS, Avalos BR, Penza SL, Marcucci G, Byrd JC, Kalaycio ME, Sobecks RM, Pohlman B, Brown S, Elder PJ, Copelan EA. Blum W, et al. Among authors: avalos br. Biol Blood Marrow Transplant. 2006 Jan;12(1):61-7. doi: 10.1016/j.bbmt.2005.06.004. Biol Blood Marrow Transplant. 2006. PMID: 16399569 Free article.

2

Alternate applications of immunoglobulin following bone marrow transplantation.

Copelan EA, Avalos BR, Kapoor N, Bechtel T, Tutschka PJ. Copelan EA, et al. Among authors: avalos br. Semin Hematol. 1992 Jul;29(3 Suppl 2):96-9. Semin Hematol. 1992. PMID: 1324531 Review. No abstract available.

3

Psoralen plus ultraviolet A (PUVA) in the treatment of chronic graft versus host disease: preliminary experience in standard treatment resistant patients.

Kapoor N, Pelligrini AE, Copelan EA, Cunningham I, Avalos BR, Klein JL, Tutschka PJ. Kapoor N, et al. Among authors: avalos br. Semin Hematol. 1992 Apr;29(2):108-12. Semin Hematol. 1992. PMID: 1594942 No abstract available.

4

Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.

Copelan EA, Biggs JC, Avalos BR, Szer J, Cunningham I, Klein JP, Atkinson K, Kapoor N, Klein JL, Downs K, et al. Copelan EA, et al. Among authors: avalos br. J Clin Oncol. 1992 Feb;10(2):237-42. doi: 10.1200/JCO.1992.10.2.237. J Clin Oncol. 1992. PMID: 1732424

5

Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2.

Copelan EA, Biggs JC, Thompson JM, Crilley P, Szer J, Klein JP, Kapoor N, Avalos BR, Cunningham I, Atkinson K, et al. Copelan EA, et al. Among authors: avalos br. Blood. 1991 Aug 1;78(3):838-43. Blood. 1991. PMID: 1859895 Free article. Clinical Trial.

6

Cyclosporine-associated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative therapy.

Ghany AM, Tutschka PJ, McGhee RB Jr, Avalos BR, Cunningham I, Kapoor N, Copelan EA. Ghany AM, et al. Among authors: avalos br. Transplantation. 1991 Aug;52(2):310-5. doi: 10.1097/00007890-199108000-00024. Transplantation. 1991. PMID: 1871805

7

Allogeneic bone marrow transplantation for leukemia using chemotherapy as conditioning: 6-year results of a single institution trial.

Tutschka PJ, Copelan EA, Kapoor N, Avalos BR, Klein JP. Tutschka PJ, et al. Among authors: avalos br. Transplant Proc. 1991 Feb;23(1 Pt 2):1709-10. Transplant Proc. 1991. PMID: 1989335 No abstract available.

8

Controlled trial of orally administered immunoglobulin following bone marrow transplantation.

Copelan EA, Bechtel TP, Klein JP, Klein JL, Tutschka P, Kapoor N, Featheringham NC, Avalos BR. Copelan EA, et al. Among authors: avalos br. Bone Marrow Transplant. 1994 Jan;13(1):87-91. Bone Marrow Transplant. 1994. PMID: 7517256 Clinical Trial.

9

The active monomeric form of macrophage inflammatory protein-1 alpha interacts with high- and low-affinity classes of receptors on human hematopoietic cells.

Avalos BR, Bartynski KJ, Elder PJ, Kotur MS, Burton WG, Wilkie NM. Avalos BR, et al. Blood. 1994 Sep 15;84(6):1790-801. Blood. 1994. PMID: 7521690 Free article.

10

Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.

Kalaycioglu M, Copelan E, Avalos B, Klein J, Goormastic M, Bolwell B. Kalaycioglu M, et al. Bone Marrow Transplant. 1995 Jan;15(1):105-10. Bone Marrow Transplant. 1995. PMID: 7742742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters